Skip to main content
Erschienen in: Current Hepatology Reports 3/2018

02.06.2018 | Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?

verfasst von: Elliot B. Tapper, Roberto Martinez-Macias, Andres Duarte-Rojo

Erschienen in: Current Hepatology Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In spite of the many health benefits attributed to exercise, reports summarizing the literature in patients with cirrhosis are scarce. We aimed to provide a comprehensive review focusing on potential safety considerations in cirrhosis.

Recent Findings

Diminished exercise capacity in patients with cirrhosis worsens their prognosis before and after liver transplantation. Exercise poses unique challenges in this population, raising questions of safety—worsening portal hypertension and malnutrition—and efficacy. In this review, we show that the balance of evidence supports supervised exercise programs with demonstrable benefits with respect to portal pressure, functional capacity, and muscle mass indexes. There are also benefits regarding their emotional function and perceived general health. Key to interpreting the benefits and risk profile of exercise is the impact of non-selective beta-blockage.

Summary

Patients with cirrhosis, with or without portal hypertension, should receive an exercise prescription as part of their standard of care. However, some standard safety recommendations should be universally followed.
Literatur
1.
Zurück zum Zitat Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–90.CrossRef Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–90.CrossRef
2.
Zurück zum Zitat Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–53.CrossRef Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–53.CrossRef
3.
Zurück zum Zitat Patel AA, Walling AM, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.CrossRef Patel AA, Walling AM, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.CrossRef
4.
Zurück zum Zitat Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology 2017. https://doi.org/10.1002/hep.29473. [Epub ahead of print]. Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology 2017. https://​doi.​org/​10.​1002/​hep.​29473. [Epub ahead of print].
5.
Zurück zum Zitat Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30. e1.CrossRef Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30. e1.CrossRef
6.
Zurück zum Zitat Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.CrossRef Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.CrossRef
7.
Zurück zum Zitat Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S. Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14:88–95.CrossRef Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S. Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14:88–95.CrossRef
8.
Zurück zum Zitat Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, Mcphail MJ, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54–62.CrossRef Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, Mcphail MJ, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54–62.CrossRef
9.
Zurück zum Zitat Prentis JM, Manas DM, Trenell MI, Hudson M, Jones DJ, Snowden CP. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–9.CrossRef Prentis JM, Manas DM, Trenell MI, Hudson M, Jones DJ, Snowden CP. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–9.CrossRef
10.
Zurück zum Zitat • Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6. Initial description of increased portal pressure associated with exercise. CrossRef • Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6. Initial description of increased portal pressure associated with exercise. CrossRef
11.
Zurück zum Zitat Bandi JC, García-Pagán JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology (Baltimore, Md). 1998;28:677–82.CrossRef Bandi JC, García-Pagán JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology (Baltimore, Md). 1998;28:677–82.CrossRef
12.
Zurück zum Zitat •• Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180. Randomized controlled trial showing a decrease in portal pressure in relation to an exercise program. CrossRef •• Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180. Randomized controlled trial showing a decrease in portal pressure in relation to an exercise program. CrossRef
13.
Zurück zum Zitat •• Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305. The largest non-controlled clinical trial showing a decrease in portal pressure as a result of weight loss and exercise. CrossRef •• Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305. The largest non-controlled clinical trial showing a decrease in portal pressure as a result of weight loss and exercise. CrossRef
14.
Zurück zum Zitat Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017;66:142–52.CrossRef Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017;66:142–52.CrossRef
15.
Zurück zum Zitat Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 2016;14:1398–411.CrossRef Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 2016;14:1398–411.CrossRef
16.
Zurück zum Zitat •• Roman E, Torrades MT, Nadal MJ, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–75. A randomized controlled trial using a supervised intervention along with amino acid supplementation expected to positively impact on sarcopenia. CrossRef •• Roman E, Torrades MT, Nadal MJ, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–75. A randomized controlled trial using a supervised intervention along with amino acid supplementation expected to positively impact on sarcopenia. CrossRef
17.
Zurück zum Zitat Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS One. 2016;11:e0151652.CrossRef Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS One. 2016;11:e0151652.CrossRef
18.
Zurück zum Zitat Debette-Gratien M, Tabouret T, Antonini M-T, Dalmay F, Carrier P, Legros R, et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015;99:145–50.CrossRef Debette-Gratien M, Tabouret T, Antonini M-T, Dalmay F, Carrier P, Legros R, et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015;99:145–50.CrossRef
19.
Zurück zum Zitat Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–6 e2.CrossRef Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–6 e2.CrossRef
20.
Zurück zum Zitat •• Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99. A randomized controlled trial with positive results on aerobic fitness, using a novel approach including home-based exercise and physical trainers. CrossRef •• Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99. A randomized controlled trial with positive results on aerobic fitness, using a novel approach including home-based exercise and physical trainers. CrossRef
21.
Zurück zum Zitat Konishi I, Hiasa Y, Tokumoto Y, Abe M, Furukawa S, Toshimitsu K, et al. Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res. 2011;41:928–35.CrossRef Konishi I, Hiasa Y, Tokumoto Y, Abe M, Furukawa S, Toshimitsu K, et al. Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res. 2011;41:928–35.CrossRef
22.
Zurück zum Zitat Pattullo V, Duarte-Rojo A, Soliman W, Vargas-Vorackova F, Sockalingam S, Fantus IG, et al. A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver Int. 2013;33:410–9.CrossRef Pattullo V, Duarte-Rojo A, Soliman W, Vargas-Vorackova F, Sockalingam S, Fantus IG, et al. A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver Int. 2013;33:410–9.CrossRef
23.
Zurück zum Zitat Nishida Y, Ide Y, Okada M, Otsuka T, Eguchi Y, Ozaki I, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193–200.CrossRef Nishida Y, Ide Y, Okada M, Otsuka T, Eguchi Y, Ozaki I, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193–200.CrossRef
24.
Zurück zum Zitat Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRef Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRef
25.
Zurück zum Zitat Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology (Baltimore, Md). 2016;63:1184–9.CrossRef Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology (Baltimore, Md). 2016;63:1184–9.CrossRef
26.
Zurück zum Zitat • Ney M, Haykowsky M, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre-and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther. 2016;44:796–806. A systematic review evaluating the importance of cardiopulmonary endurance in prognostication of liver transplant candidates. CrossRef • Ney M, Haykowsky M, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre-and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther. 2016;44:796–806. A systematic review evaluating the importance of cardiopulmonary endurance in prognostication of liver transplant candidates. CrossRef
27.
Zurück zum Zitat Wallen MP, Hall A, Dias KA, Ramos JS, Keating SE, Woodward AJ, et al. Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease. Aliment Pharmacol Ther. 2017;46:741–7.CrossRef Wallen MP, Hall A, Dias KA, Ramos JS, Keating SE, Woodward AJ, et al. Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease. Aliment Pharmacol Ther. 2017;46:741–7.CrossRef
28.
Zurück zum Zitat Bandi JC, Garcia-Pagan JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998;28:677–82.CrossRef Bandi JC, Garcia-Pagan JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998;28:677–82.CrossRef
29.
Zurück zum Zitat Salo J, Guevara M, Fernandez-Esparrach G, Bataller R, Gines A, Jimenez W, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRef Salo J, Guevara M, Fernandez-Esparrach G, Bataller R, Gines A, Jimenez W, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRef
30.
Zurück zum Zitat Eriksson LS, Broberg S, Bjorkman O, Wahren J. Ammonia metabolism during exercise in man. Clin Physiol. 1985;5:325–36.CrossRef Eriksson LS, Broberg S, Bjorkman O, Wahren J. Ammonia metabolism during exercise in man. Clin Physiol. 1985;5:325–36.CrossRef
31.
Zurück zum Zitat Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol. 2005;563:285–90.CrossRef Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol. 2005;563:285–90.CrossRef
32.
Zurück zum Zitat Yuan Y, Chan KM. A longitudinal study on the ammonia threshold in junior cyclists. Br J Sports Med. 2004;38:115–9.CrossRef Yuan Y, Chan KM. A longitudinal study on the ammonia threshold in junior cyclists. Br J Sports Med. 2004;38:115–9.CrossRef
33.
Zurück zum Zitat Dietrich R, Bachmann C, Lauterburg BH. Exercise-induced hyperammonemia in patients with compensated chronic liver disease. Scand J Gastroenterol. 1990;25:329–34.CrossRef Dietrich R, Bachmann C, Lauterburg BH. Exercise-induced hyperammonemia in patients with compensated chronic liver disease. Scand J Gastroenterol. 1990;25:329–34.CrossRef
34.
Zurück zum Zitat Soriano G, Roman E, Cordoba J, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55:1922–30.CrossRef Soriano G, Roman E, Cordoba J, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55:1922–30.CrossRef
35.
Zurück zum Zitat Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med. 2004;34:293–306.CrossRef Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med. 2004;34:293–306.CrossRef
36.
Zurück zum Zitat Chatard JC, Mujika I, Goiriena JJ, Carre F. Screening young athletes for prevention of sudden cardiac death: practical recommendations for sports physicians. Scand J Med Sci Sports. 2016;26:362–74.CrossRef Chatard JC, Mujika I, Goiriena JJ, Carre F. Screening young athletes for prevention of sudden cardiac death: practical recommendations for sports physicians. Scand J Med Sci Sports. 2016;26:362–74.CrossRef
37.
Zurück zum Zitat Kazankov K, Munk K, Ovrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Investig. 2017;47:565–73.CrossRef Kazankov K, Munk K, Ovrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Investig. 2017;47:565–73.CrossRef
38.
Zurück zum Zitat Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605–13.CrossRef Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605–13.CrossRef
39.
Zurück zum Zitat Hupin D, Edouard P, Oriol M, Laukkanen J, Abraham P, Doutreleau S, et al. Exercise electrocardiogram in middle-aged and older leisure time sportsmen: 100 exercise tests would be enough to identify one silent myocardial ischemia at risk for cardiac event. Int J Cardiol. 2018;257:16–23.CrossRef Hupin D, Edouard P, Oriol M, Laukkanen J, Abraham P, Doutreleau S, et al. Exercise electrocardiogram in middle-aged and older leisure time sportsmen: 100 exercise tests would be enough to identify one silent myocardial ischemia at risk for cardiac event. Int J Cardiol. 2018;257:16–23.CrossRef
40.
Zurück zum Zitat Riebe D, Franklin BA, Thompson PD, et al. Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47:2473–9.CrossRef Riebe D, Franklin BA, Thompson PD, et al. Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47:2473–9.CrossRef
41.
Zurück zum Zitat Ezaz G, Murphy SL, Mellinger J, Tapper EB. Increased morbidity and mortality associated with falls among patients with cirrhosis. Am J Med. 2018;131:645–650.e2.CrossRef Ezaz G, Murphy SL, Mellinger J, Tapper EB. Increased morbidity and mortality associated with falls among patients with cirrhosis. Am J Med. 2018;131:645–650.e2.CrossRef
42.
Zurück zum Zitat United States. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! Washington, DC: U.S. Dept. of Health and Human Services; 2008. United States. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! Washington, DC: U.S. Dept. of Health and Human Services; 2008.
43.
Zurück zum Zitat Lai CC, Tu YK, Wang TG, Huang YT, Chien KL. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47:367–73.CrossRef Lai CC, Tu YK, Wang TG, Huang YT, Chien KL. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47:367–73.CrossRef
44.
Zurück zum Zitat Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplast. 2005;20:460–6.CrossRef Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplast. 2005;20:460–6.CrossRef
45.
Zurück zum Zitat Bhasin S, Apovian CM, Travison TG, Pencina K, Moore LL, Huang G, et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern Med. 2018;178:530–41.CrossRef Bhasin S, Apovian CM, Travison TG, Pencina K, Moore LL, Huang G, et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern Med. 2018;178:530–41.CrossRef
46.
Zurück zum Zitat • Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39. Comprehensive review on the role of disorders of physical function disorders/sarcopenia and exercise in liver transplant candidates. CrossRef • Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39. Comprehensive review on the role of disorders of physical function disorders/sarcopenia and exercise in liver transplant candidates. CrossRef
Metadaten
Titel
Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?
verfasst von
Elliot B. Tapper
Roberto Martinez-Macias
Andres Duarte-Rojo
Publikationsdatum
02.06.2018
Verlag
Springer US
Erschienen in
Current Hepatology Reports / Ausgabe 3/2018
Elektronische ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-018-0404-z

Weitere Artikel der Ausgabe 3/2018

Current Hepatology Reports 3/2018 Zur Ausgabe

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-induced Liver Injury Associated with Weight Loss Supplements

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-Induced Liver Injury in Children

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Uncommon Presentations of Idiosyncratic Drug-Induced Liver Injury

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

The Portosystemic Shunt Syndrome and Role of Shunt Embolization in the Management of Hepatic Encephalopathy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.